The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
Zydus has developed an innovative formulation of Semaglutide Injection in a prefilled cartridge administered using a reusable patient-friendly pen device
Company to launch product after the expiry of semaglutide patent in India
The deal also includes upfront licensing fees and milestone-based payments from Lupin to Zydus
Zydus has developed an innovative Semaglutide Injection (15 mg/3 ml) in a prefilled cartridge administered using a patient-friendly reusable pen for which the company has exclusive rights
Semaglutide is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus
The company has posted net profit of Rs. 4,064.9 crore for the 9 months period ended December 31, 2025
Emcure becomes the first Indian company to exclusively distribute and commercialise Poviztra, a second brand of Novo Nordisk’s Semaglutide injection for weight management
Poviztra is a second brand of Wegovy
Subscribe To Our Newsletter & Stay Updated
